Northern Trust’s Alnylam Pharmaceuticals ALNY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $380M | Buy |
|
|||||
|
2025
Q2 | $271M | Sell |
|
|||||
|
2025
Q1 | $234M | Sell |
|
|||||
|
2024
Q4 | $207M | Buy |
|
|||||
|
2024
Q3 | $202M | Sell |
|
|||||
|
2024
Q2 | $190M | Buy |
|
|||||
|
2024
Q1 | $111M | Sell |
|
|||||
|
2023
Q4 | $146M | Sell |
|
|||||
|
2023
Q3 | $141M | Buy |
|
|||||
|
2023
Q2 | $147M | Buy |
|
|||||
|
2023
Q1 | $153M | Buy |
|
|||||
|
2022
Q4 | $178M | Buy |
|
|||||
|
2022
Q3 | $147M | Sell |
|
|||||
|
2022
Q2 | $107M | Sell |
|
|||||
|
2022
Q1 | $125M | Sell |
|
|||||
|
2021
Q4 | $130M | Sell |
|
|||||
|
2021
Q3 | $147M | Buy |
|
|||||
|
2021
Q2 | $120M | Sell |
|
|||||
|
2021
Q1 | $106M | Buy |
|
|||||
|
2020
Q4 | $96.5M | Sell |
|
|||||
|
2020
Q3 | $110M | Sell |
|
|||||
|
2020
Q2 | $115M | Buy |
|
|||||
|
2020
Q1 | $75.8M | Buy |
|
|||||
|
2019
Q4 | $76.8M | Buy |
|
|||||
|
2019
Q3 | $53.6M | Buy |
|
|||||
|
2019
Q2 | $41.4M | Buy |
|
|||||
|
2019
Q1 | $52.2M | Buy |
|
|||||
|
2018
Q4 | $38.8M | Buy |
|
|||||
|
2018
Q3 | $43.3M | Buy |
|
|||||
|
2018
Q2 | $48.5M | Buy |
|
|||||
|
2018
Q1 | $56.2M | Sell |
|
|||||
|
2017
Q4 | $60.3M | Buy |
|
|||||
|
2017
Q3 | $44.3M | Sell |
|
|||||
|
2017
Q2 | $30.1M | Buy |
|
|||||
|
2017
Q1 | $18.4M | Buy |
|
|||||
|
2016
Q4 | $13M | Sell |
|
|||||
|
2016
Q3 | $25.2M | Buy |
|
|||||
|
2016
Q2 | $20.2M | Buy |
|
|||||
|
2016
Q1 | $22.2M | Buy |
|
|||||
|
2015
Q4 | $32M | Sell |
|
|||||
|
2015
Q3 | $32.6M | Sell |
|
|||||
|
2015
Q2 | $51M | Buy |
|
|||||
|
2015
Q1 | $33.6M | Buy |
|
|||||
|
2014
Q4 | $26.8M | Sell |
|
|||||
|
2014
Q3 | $21.6M | Sell |
|
|||||
|
2014
Q2 | $41.9M | Sell |
|
|||||
|
2014
Q1 | $51.5M | Sell |
|
|||||
|
2013
Q4 | $52.8M | Buy |
|
|||||
|
2013
Q3 | $51.6M | Buy |
|
|||||
|
2013
Q2 | $24.5M | Buy |
|